All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @supersxcgemabackupltd on TikTok · 174s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @supersxcgemabackupltd's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Oni! So, guess what I've got? I have needles and I have the pen which means today is going
  2. 0:09to be the first day that I do start my set of gender journey. So, obviously, move past
  3. 0:20this bad boy. It is obviously first thing in the morning, this is obviously I will walk
  4. 0:26to the school. Anyway, this is the dog fur. So, I'm going to have some breakfast first
  5. 0:34because I have been told obviously it's a little bit, it's better for the obvious to
  6. 0:37the sickness feelings and whatever. If you have obviously a light meal before you do your
  7. 0:41injection, I don't know! So, it's a journey, so we will see. We will learn along the way.
  8. 0:48So, I'm going to have some brand flakes and then obviously we're going to do first injection
  9. 0:55in the morning and obviously I will keep you updated as my day goes on and then I will
  10. 1:01post obviously the video later on in the evening so then obviously you can see the full day rather
  11. 1:05than bits, bobs and parts. Right, so I've got my pen, I've put my needle on, it's quite
  12. 1:12cool, that is. I've turned it to obviously the flow check thing, you can you see the little
  13. 1:16dots? Because you have to, apparently you have to loosen first, if said. So, I don't know,
  14. 1:28flow check, we're going with it. I'm not taking that green finger off because it's bacteria yet
  15. 1:32till I put it in. And then obviously we put it to the dosage which we start off at six and then
  16. 1:46obviously we inject it an old it for 10 seconds I think. But yeah, I'm not obviously going to
  17. 1:53inject it whilst I'm on camera because I don't know, I don't know if I can get banned for that
  18. 1:57or whether some people might find it weird. Anyway, so I want to inject and then obviously I will
  19. 2:02keep you updated, how I feel, I feel like I did that. Right, so quick update, obviously the needle
  20. 2:09was absolutely falling this morning, not painful at all, it is only little and stop moving and
  21. 2:20yeah, all day I felt fine. I have now gone toyered but I can't put that down to my sex
  22. 2:26obviously with depression I do go up and down so I can't, cannot say it's that.
  23. 2:32So yeah, so far so good. I have had brand flags this morning, I've had a non-to-summit calorie bar
  24. 2:39this afternoon and then I have had sandwich with 30% less fat crisps tonight and obviously
  25. 2:48cups of teas and lots of water. Let's sort out day two tomorrow.

Saxenda on TikTok: separating liraglutide facts from viral hype

supersxcgemabackupltd

TikTok creator

167.5K viewsWatch on TikTok

Quick answer

The creator is self-documenting day one of Saxenda (liraglutide 3.0mg, injectable GLP-1 agonist) use, describing standard injection technique including flow check and dose setting. They report no immediate adverse effects but note fatigue, a documented early side effect in the SCALE trial, which they attribute instead to pre-existing depression. Their food intake appears calorie-restricted but does not reflect the structured dietary support recommended alongside Saxenda in clinical practice.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Saxenda on TikTok: separating liraglutide facts from viral hype, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Saxenda on TikTok: separating liraglutide facts from viral hype is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Saxenda on TikTok: separating liraglutide facts from viral hype" from supersxcgemabackupltd. We read the clip as a GLP-1 social video fact-checks claim about GLP-1 social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is self-documenting day one of Saxenda (liraglutide 3.

The reason this review is not generic is the source wording and the canonical claim label "glp1 foryou fyp saxenda." In this clip, the useful excerpt is: "Oni!" That wording changes the review because it points to GLP-1 social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. GLP-1 social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The Saxenda pen's official instructions specify holding the needle in place for at least 6 seconds after pressing the dose button, not 10 seconds as the creator stated, though 10 seconds is not clinically harmful.
People who land here are usually comparing the GLP-1 social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' GLP-1 social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator is self-documenting day one of Saxenda (liraglutide 3.

FormBlends verdict

GLP-1 social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator is self-documenting day one of Saxenda (liraglutide 3.0mg, injectable GLP-1 agonist) use, describing standard injection technique including flow check and dose setting. They report no immediate adverse effects but note fatigue, a documented early side effect in the SCALE trial, which they attribute instead to pre-existing depression. Their food intake appears calorie-restricted but does not reflect the structured dietary support recommended alongside Saxenda in clinical practice.
  • Nausea affects approximately 39% of Saxenda users according to the SCALE Obesity and Prediabetes trial (Pi-Sunyer et al., 2015, NEJM), making it the most common early adverse event, not a minor edge case.
  • The Saxenda pen's official instructions specify holding the needle in place for at least 6 seconds after pressing the dose button, not 10 seconds as the creator stated, though 10 seconds is not clinically harmful.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Nausea affects approximately 39% of Saxenda users according to the SCALE Obesity and Prediabetes trial (Pi-Sunyer et al., 2015, NEJM), making it the most common early adverse event, not a minor edge case.
  • The Saxenda pen's official instructions specify holding the needle in place for at least 6 seconds after pressing the dose button, not 10 seconds as the creator stated, though 10 seconds is not clinically harmful.
  • Fatigue on day one of liraglutide use may be medication-related, not solely due to pre-existing conditions; Davies et al. (2015, Diabetes Care) listed fatigue among early systemic complaints in GLP-1 trials.
  • Saxenda is a prescription-only medicine in the UK, indicated for adults with BMI of 30 or above, or BMI of 27 or above with a weight-related health condition, and it requires clinical assessment before prescribing.
  • GI side effects are the leading cause of discontinuation in liraglutide trials; structured dose escalation schedules exist specifically to reduce early nausea and improve tolerability.
  • Saxenda is licensed as an adjunct to a reduced-calorie diet and increased physical activity, not as a standalone intervention. The dietary approach shown in this video does not represent the supervised support used in clinical trials.
  • Saxenda contains liraglutide and is distinct from semaglutide-based medications such as Ozempic or Wegovy. These are different molecules with different dosing, delivery, and trial profiles and should not be treated as interchangeable.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @supersxcgemabackupltd actually say?

The creator documented their first day injecting Saxenda (liraglutide), a GLP-1 receptor agonist used for weight management. They said eating a light meal before injecting helps with nausea, described the flow check process, and held the injection for what they believed was around 10 seconds. They also noted feeling tired later in the day but attributed that to depression rather than the medication, which shows some genuine caution about jumping to conclusions.

Throughout the video, they were candid about not being certain: "I don't know, so it's a journey, so we will see." Their food diary for the day included bran flakes, a low-calorie bar, a sandwich with lower-fat crisps, tea, and water. No specific calorie targets or dosing advice were given, which is worth noting.

Does the science back this up?

The claim that eating before injecting reduces nausea is broadly consistent with clinical evidence, though the mechanism is more nuanced than the creator implies. Liraglutide slows gastric emptying, and injecting on a completely empty stomach can intensify nausea in some patients, though the evidence is not watertight on meal timing specifically.

The SCALE Obesity and Prediabetes trial (Pi-Sunyer et al., 2015, New England Journal of Medicine) established liraglutide 3.0mg as effective for weight loss, but the majority of the 3,731 participants experienced gastrointestinal side effects, particularly early in treatment. The manufacturer's prescribing information confirms nausea as the most common adverse event, affecting roughly 39% of users. Fatigue is also a documented side effect, appearing in clinical trial data, so the creator's tiredness on day one cannot be dismissed as entirely unrelated to the drug, even if their depression is a plausible confounding factor.

What did they get wrong (or right)?

Credit where it is due: the flow check step they described is correct. Saxenda pens require a flow check before first use to confirm the pen is working and to remove air from the needle. The creator handled this accurately.

Where things get shakier is the "hold for 10 seconds" claim. Novo Nordisk's official Saxenda instructions specify holding the pen in place for at least 6 seconds after the button is fully pressed. Ten seconds is not dangerous, but it is not the stated guidance either. Small inaccuracies in injection technique can affect dose delivery, so getting this right matters.

The food diary the creator shared, a low-calorie bar and a sandwich with reduced-fat crisps, is not evidence of a medically supervised meal plan. Saxenda is typically prescribed alongside structured dietary and behavioural support. Going it alone based on TikTok trial-and-error is not the same as that, and the creator's audience should understand the difference.

What should you actually know?

Saxenda is a prescription-only medication in the UK and most other countries. It requires a licensed prescriber to assess whether it is appropriate for you, including a review of contraindications such as a personal or family history of medullary thyroid carcinoma or MEN2. The SCALE trial population had BMI over 27 with at least one weight-related comorbidity, or BMI over 30. It is not a casual starter kit.

Nausea, vomiting, diarrhoea, and fatigue are the most commonly reported early side effects, and dose escalation schedules exist specifically to reduce their severity. The creator's day-one experience of minimal discomfort is not universal. Davies et al. (2015, Diabetes Care) found that GI events were the primary reason for discontinuation in liraglutide trials.

If you are considering a GLP-1 medication, the conversation starts with a clinician, not a TikTok comment section.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

supersxcgemabackupltd · TikTok creator

167.5K views on this video

#foryou #fyp #saxenda

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about nausea affects approximately 39% of saxenda users according to the?

Nausea affects approximately 39% of Saxenda users according to the SCALE Obesity and Prediabetes trial (Pi-Sunyer et al., 2015, NEJM), making it the most common early adverse event, not a minor edge case.

What does the video say about the saxenda pen's official instructions specify holding the needle in?

The Saxenda pen's official instructions specify holding the needle in place for at least 6 seconds after pressing the dose button, not 10 seconds as the creator stated, though 10 seconds is not clinically harmful.

What does the video say about fatigue on day one of liraglutide use may be medication-related,?

Fatigue on day one of liraglutide use may be medication-related, not solely due to pre-existing conditions; Davies et al. (2015, Diabetes Care) listed fatigue among early systemic complaints in GLP-1 trials.

What does the video say about saxenda?

Saxenda is a prescription-only medicine in the UK, indicated for adults with BMI of 30 or above, or BMI of 27 or above with a weight-related health condition, and it requires clinical assessment before prescribing.

What does the video say about gi side effects?

GI side effects are the leading cause of discontinuation in liraglutide trials; structured dose escalation schedules exist specifically to reduce early nausea and improve tolerability.

What does the video say about saxenda?

Saxenda is licensed as an adjunct to a reduced-calorie diet and increased physical activity, not as a standalone intervention. The dietary approach shown in this video does not represent the supervised support used in clinical trials.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by supersxcgemabackupltd, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.